ARCII: A Phase II Trial of the HIV Protease Inhibitor Nelfinavir in Combination With Chemoradiation for Locally Advanced Inoperable Pancreatic Cancer
Radiotherapy and Oncology - Netherlands
doi 10.1016/j.radonc.2016.03.021
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV